OR WAIT null SECS
February 24, 2022
Scottish Enterprise has awarded £20 million (US$27 million) to Valneva Scotland to advance vaccine development.
February 23, 2022
Alvea has begun preclinical testing of a scalable, shelf-stable DNA vaccine against SARS-CoV-2 variants.
Sanofi and GSK announce they are seeking regulatory authorization for COVID-19 vaccine.
Novavax announces the first doses of Nuvaxovid COVID-19 vaccine have begun shipping to European Union member states.
February 22, 2022
Noema Pharma announces first patient dosed in its Phase IIb clinical trial of mGluR5 inhibitor NOE-101 in trigeminal neuralgia.
February 21, 2022
The turnkey facilities will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa.
February 18, 2022
Health Canada authorizes Novavax COVID-19 vaccine for individuals 18 years of age and older.
FDA has approved Pyrukynd (mitapivat) tablets to treat hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
The company has announced plans to establish a commercial presence in six European countries.
February 17, 2022
The commercialization and licensing deal will see Biogen commercialize Xbrane’s Xcimzane, a proposed biosimilar for CIMZIA (certolizumab pegol).